Zobrazeno 1 - 10
of 23
pro vyhledávání: '"J D, Yager"'
Publikováno v:
Cancer research. 61(20)
Many of the major identified risk factors for breast cancer are associated with exposure to endogenous estrogen. In addition to the effects of estrogen as a growth factor, experimental and epidemiological evidence suggest that catechol metabolites of
Autor:
J D, Yager
Publikováno v:
Journal of the National Cancer Institute. Monographs. (27)
A common thread linking the main risks for developing breast cancer in women is cumulative, excessive exposure to estrogen. The standard paradigm to account for this association focuses on increased cell proliferation caused by estrogen through estro
Autor:
C R, Jefcoate, J G, Liehr, R J, Santen, T R, Sutter, J D, Yager, W, Yue, S J, Santner, R, Tekmal, L, Demers, R, Pauley, F, Naftolin, G, Mor, L, Berstein
Publikováno v:
Journal of the National Cancer Institute. Monographs. (27)
Estrogen exposure represents the major known risk factor for development of breast cancer in women and is implicated in the development of prostate cancer in men. Human breast tissue has been shown to be a site of oxidative metabolism of estrogen due
Publikováno v:
Carcinogenesis. 21(6)
Ethinyl estradiol (EE) is a strong promoter of hepatocarcinogenesis in the rat. Treatment with EE and other hepatic promoters induces transient growth stimulation followed by growth inhibition (mitosuppression) in hepatocytes. Previously, we identifi
Autor:
K J, Helzlsouer, A J, Alberg, H Y, Huang, S C, Hoffman, P T, Strickland, J W, Brock, V W, Burse, L L, Needham, D A, Bell, J A, Lavigne, J D, Yager, G W, Comstock
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 8(6)
A nested case-control study was conducted to examine the association between serum concentrations of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE), the primary metabolite of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT), and polychlorinate
Autor:
J A, Lavigne, K J, Helzlsouer, H Y, Huang, P T, Strickland, D A, Bell, O, Selmin, M A, Watson, S, Hoffman, G W, Comstock, J D, Yager
Publikováno v:
Cancer research. 57(24)
Mounting evidence suggests that catechol metabolites of estradiol may contribute to the development of estrogen-induced cancers. O-Methylation, catalyzed by catechol-O-methyltransferase (COMT), inactivates catechol estrogens. COMT is polymorphic in t
Publikováno v:
Carcinogenesis. 17(12)
In this study, our goal was to identify genes whose expression in liver is altered in female F-344 rats during mitosuppression induced by 42 days of ethinyl estradiol (EE) treatment (Yager et al., Carcinogenesis, 15, 2117-2123, 1994). Northern analys
Publikováno v:
Hepatology (Baltimore, Md.). 22(1)
A problem traditionally encountered with primary hepatocyte cultures is their rapid dedifferentiation, which is reflected not only in decreased liver-specific functions, but also in dedifferentiated morphology: the cells flatten, depolarize, and lose
Autor:
N, Ni, J D, Yager
Publikováno v:
Hepatology (Baltimore, Md.). 19(1)
Ethinyl estradiol is a weak complete carcinogen and potent tumor promoter. In vivo, ethinyl estradiol causes a rapid but transient increase in liver growth, whereas in cultured female hepatocytes it enhances DNA synthesis induced by epidermal growth
Autor:
J D, Yager, Y E, Shi
Publikováno v:
Progress in clinical and biological research. 369